Recherche
-
Molecular dissection of protein-protein interactions between integrin α5β1 and the Helicobacter pylori Cag type IV secretion system.
(FEBS Journal. vol. 284, n° 23, pp. 4143-4157, 2017-12-01)Article de revueLibre accès -
Protoparvovirus Knocking at the Nuclear Door.
(Viruses. vol. 9, n° 10, 2017-10-02)Article de revueLibre accès -
High-Level Resistance to Colistin Mediated by Various Mutations in the Gene among Carbapenemase-Producing Klebsiella pneumoniae.
(Antimicrobial Agents and Chemotherapy. vol. 61, n° 11, 2017-11-01)Article de revueLibre accès -
Predominance of CRF06_cpx and Transmitted HIV Resistance in Algeria: Update 2013-2014.
(AIDS Research and Human Retroviruses. vol. 32, n° 4, pp. 370-2, 2016-04-01)Article de revueLibre accès -
Targeted immunotherapy of high-grade cervical intra-epithelial neoplasia: Expectations from clinical trials.
(Molecular and Clinical Oncology. vol. 8, n° 2, pp. 227-235, 2018-02-01)Article de revueLibre accès -
Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.
(American Journal of Transplantation. vol. 16, n° 8, pp. 2384-94, 2016-08-01)Article de revueLibre accès -
Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
(Journal of Antimicrobial Chemotherapy. vol. 74, n° 3, pp. 618-624, 2019-03-01)Article de revueLibre accès -
4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors.
(ACS Medicinal Chemistry Letters. vol. 4, n° 7, pp. 606-11, 2013-07-11)Article de revueLibre accès -
Increased colistin resistance upon acquisition of the plasmid-mediated mcr-1 gene in Escherichia coli isolates with chromosomally encoded reduced susceptibility to polymyxins.
(International Journal of Antimicrobial Agents. vol. 50, n° 3, pp. 503-504, 2017-09-01)Article de revue -
Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosa
(Antimicrobial Agents and Chemotherapy. vol. 63, n° 1, 2019-01-01)Article de revueLibre accès